Feedback / Questions
tarcocimab tedromer (KSI 301) - Kodiak Sciences
https://www.prnewswire.com/news-releases/kodiak-sciences-announces-treatment-of-first-patients-in-phase-3-glow2-study-of-tarcocimab-tedromer-in-diabetic-retinopathy-302144051.html
May 13, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next